[go: up one dir, main page]

GB2363377B - Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof - Google Patents

Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof

Info

Publication number
GB2363377B
GB2363377B GB0014375A GB0014375A GB2363377B GB 2363377 B GB2363377 B GB 2363377B GB 0014375 A GB0014375 A GB 0014375A GB 0014375 A GB0014375 A GB 0014375A GB 2363377 B GB2363377 B GB 2363377B
Authority
GB
United Kingdom
Prior art keywords
pyrimidinediones
therapeutic uses
novel thieno
thieno
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0014375A
Other versions
GB2363377A (en
GB0014375D0 (en
Inventor
Anthony Ingall
John Bantick
Matthew Perry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0014375A priority Critical patent/GB2363377B/en
Publication of GB0014375D0 publication Critical patent/GB0014375D0/en
Publication of GB2363377A publication Critical patent/GB2363377A/en
Application granted granted Critical
Publication of GB2363377B publication Critical patent/GB2363377B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
GB0014375A 2000-06-14 2000-06-14 Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof Expired - Fee Related GB2363377B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0014375A GB2363377B (en) 2000-06-14 2000-06-14 Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0014375A GB2363377B (en) 2000-06-14 2000-06-14 Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof

Publications (3)

Publication Number Publication Date
GB0014375D0 GB0014375D0 (en) 2000-08-02
GB2363377A GB2363377A (en) 2001-12-19
GB2363377B true GB2363377B (en) 2004-06-09

Family

ID=9893514

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0014375A Expired - Fee Related GB2363377B (en) 2000-06-14 2000-06-14 Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof

Country Status (1)

Country Link
GB (1) GB2363377B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109963858A (en) * 2016-09-23 2019-07-02 拜耳股份公司 N3The thieno uracil and application thereof that ring-type replaces
CN113816970A (en) * 2021-09-18 2021-12-21 济宁医学院附属医院 Selective copper ion chelating agent, preparation method thereof and application thereof in pulmonary fibrosis

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890923B2 (en) * 2002-12-16 2005-05-10 Astrazeneca Ab Compounds
WO2016118825A1 (en) 2015-01-22 2016-07-28 The Scripps Research Institute Heterocyclic inhibitors of monocarboxylate transporters
UY36586A (en) * 2015-03-26 2016-10-31 Bayer Pharma AG HETEROCICLILMETILTIENOURACILOS AND USE OF THE SAME
WO2018041771A1 (en) 2016-09-02 2018-03-08 Bayer Pharma Aktiengesellschaft (1-methylcyclopropyl)methyl-substituted thienouraciles and use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054190A1 (en) * 1997-05-28 1998-12-03 Astra Pharmaceuticals Ltd. Novel compounds
WO2000012514A1 (en) * 1998-08-28 2000-03-09 Astrazeneca Ab Novel compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054190A1 (en) * 1997-05-28 1998-12-03 Astra Pharmaceuticals Ltd. Novel compounds
WO2000012514A1 (en) * 1998-08-28 2000-03-09 Astrazeneca Ab Novel compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109963858A (en) * 2016-09-23 2019-07-02 拜耳股份公司 N3The thieno uracil and application thereof that ring-type replaces
CN113816970A (en) * 2021-09-18 2021-12-21 济宁医学院附属医院 Selective copper ion chelating agent, preparation method thereof and application thereof in pulmonary fibrosis
CN113816970B (en) * 2021-09-18 2022-08-09 济宁医学院附属医院 Selective copper ion chelating agent, preparation method thereof and application thereof in pulmonary fibrosis

Also Published As

Publication number Publication date
GB2363377A (en) 2001-12-19
GB0014375D0 (en) 2000-08-02

Similar Documents

Publication Publication Date Title
AP2002002456A0 (en) Pyrazolo '4,3-d pyrimidine derivatives
GB0004544D0 (en) Polymers their preparation and uses
IL145549A0 (en) Thienopyrimidine compounds, their production and use
PL353366A1 (en) Pyrazolo[4,3-d]pyrimidines
PL358551A1 (en) 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines
IL135982A0 (en) Fungicidal combinations comprising thieno[2,3-d]pyrimidin-4-one
GB2366254B (en) Child-vehicle pusher's raincover
AU2002213429A1 (en) Antiviral methods and compounds
IL142630A0 (en) FUNGICIDAL COMBINATIONS COMPRISING THIENO [2,3-d] PYRIMIDIN-4-ONE
GB2363377B (en) Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof
ZA987114B (en) 3-substituted 3,4,5,7-tetrahydropyrrolol[3',4':4,5] thieno[2,3-D]pyrimidine derivatives, their preparation and use.
PL363077A1 (en) Use of pyrazolo[4,3-d]pyrimidines
IL151082A0 (en) Thienopyridine derivatives, their production and use
PL356668A1 (en) Novel substituted pyrazolo[4,3-e
PL361890A1 (en) Use of pyrazolo[4,3-d]pyrimidines
PL365342A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
AU2001285785A1 (en) 2-aminoalkyl-thieno[2,3-d]pyrimidines
AU8578501A (en) 2-aminoalkyl-thieno(2,3-d)pyrimidines
PL371201A1 (en) 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
AU2002367585A8 (en) Methods of using 46828, a human acyl-coa synthetase
AU2001273148A1 (en) 57658, a human uridine kinase and uses thereof
AU2001271244A1 (en) Novel human uridine kinase
GB0012497D0 (en) Antiviral therapy
GB0000095D0 (en) Polymers their preparation and uses
GB0022753D0 (en) Polymers their preparation and uses

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20120614